SS
LSTA icon

SBI Securities’s Lisata Therapeutics LSTA Stock Holding History

SBI Securities’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24 Hold
7
– – ﹤0.01% 3813
2026
Q1 		$35 Hold
7
– – ﹤0.01% 3645
2025
Q4 		$13 Sell
7
-133
-95% -$296 ﹤0.01% 3843
2025
Q3 		$367 Hold
140
– – ﹤0.01% 3101
2025
Q2 		$406 Hold
140
– – ﹤0.01% 3047
2025
Q1 		$329 Sell
140
-400
-74% -$1.08K ﹤0.01% 3031
2024
Q4 		$1.61K Buy
+540
New +$1.54K ﹤0.01% 2384

Other funds holding LSTA

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
CVM
Cheviot Value Management Beverly Hills, California $984M AUM 24.46% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

SBI Securities's LSTA Position: Q2 2026 in Review

SBI Securities held its Lisata Therapeutics (LSTA) position steady in Q2 2026 at 7 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #3813.

SBI Securities first reported a position in LSTA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.61K in Q4 2024. 10 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • SBI Securities held 7 shares of Lisata Therapeutics worth $24 as of Q2 2026.
  • SBI Securities left its Lisata Therapeutics share count unchanged in Q2 2026.
  • Lisata Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3813 holding.
  • SBI Securities first reported a position in Lisata Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Lisata Therapeutics position peaked at $1.61K in Q4 2024.
  • 10 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.